Clinical Trial Update: A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports on maintenance therapy with PROCRIT (epoetin alfa) for anemia associated with chronic kidney disease, and the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Ortho Biotech Products, L.P. | Conditions: Anemia, Chronic Renal Insufficiency | Phase 2 | Status: COMPLETED